Publications

An efficient, non-viral arrayed CRISPR screening platform for iPSC-derived myeloid and microglia models.

Meier S, Larsen ASG, Wanke F, Mercado N, Mei A, Takacs L, Mracsko ES, Collin L, Kampmann M, Roudnicky F, Jagasia R

2025
A Massively Parallel CRISPR-Based Screening Platform for Modifiers of Neuronal Activity.

Boggess SC, Gandhi V, Tsai MC, Marzette E, Teyssier N, Yu-Ying Chou J, Hu X, Cramer A, Yadanar L, Shroff K, Jeong CG, Eidenschenk C, Hanson JE, Tian R, Kampmann M

2025
Detection of Alzheimer Neuropathology in Alzheimer and Non-Alzheimer Clinical Syndromes With Blood-Based Biomarkers.

VandeVrede L, Cho H, Sanderson-Cimino M, Wekselman F, Cobigo Y, Gorno-Tempini ML, Heuer HW, Kramer JH, Lario Lago A, Leichter D, Ljubenkov P, Miller BL, Perry DC, Rabinovici GD, Rojas JC, Rosen HJ, Saloner R, Staffaroni A, Triana-Baltzer G, Spina S, Seeley WW, Grinberg LT, Kolb HC, La Joie R, Boxer AL

2025
Halt aging? - functional HSCs lead the way.

Chu RT, Schroer AB, Villeda SA

2025
Generalizable Prediction of Alzheimer Disease Pathologies with a Scalable Annotation Tool and an High-Accuracy Model.

Gopal Ramaswamy V, Ahirwar M, Ryan G, Dugger BN, Al Dalahmah O, Signaevsky M, Purohit DP, Haroutunian V, Finkbeiner S

2025
The PRC2.1 subcomplex opposes G1 progression through regulation of CCND1 and CCND2.

Longhurst AD, Wang K, Suresh HG, Ketavarapu M, Ward HN, Jones IR, Narayan V, Hundley FV, Hassan AZ, Boone C, Myers CL, Shen Y, Ramani V, Andrews BJ, Toczyski DP

2025
Impact of Multimorbidity on Symptom Burden and Symptom Clusters in Patients Receiving Chemotherapy.

Harris C, Hammer MJ, Conley YP, Paul SM, Cooper BA, Shin J, Oppegaard K, Morse L, Levine JD, Miaskowski C

2025

Pages